The function of gamma interferon-inducible GTP-binding protein IGTP in host resistance to Toxoplasma gondii is Stat1 dependent and requires expression in both hematopoietic and nonhematopoietic cellular compartments

被引:70
作者
Collazo, CM
Yap, GS
Hieny, S
Caspar, P
Feng, CG
Taylor, GA
Sher, A
机构
[1] NIAID, Immunobiol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA
[2] Brown Univ, Dept Mol Microbiol & Immunol, Div Biol & Med, Providence, RI 02912 USA
[3] Duke Univ, Med Ctr, Dept Med, Durham, NC 27705 USA
[4] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27705 USA
[5] Durham Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Durham, NC 27705 USA
关键词
D O I
10.1128/IAI.70.12.6933-6939.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IGTP is a member of the 47-kDa family of gamma interferon (IFN-gamma)-induced GTPases. We have previously shown that IGTP is critical for host resistance to Toxoplasma gondii infection. In the present study, we demonstrate that T. gondii-induced IGTP expression in vivo and IFN-gamma-driven synthesis of the protein in vitro are dependent on Stat1. Consistent with this observation, Stat1-deficient animals succumbed to T. gondii infection with the same rapid kinetics as IGTP(-/-) mice. To ascertain the cellular levels at which IGTP functions in host control of acute infection, we constructed reciprocal bone marrow chimeras between IGTP-deficient and wild-type mice. Resistance to infection was observed only when IGTP was present in both hematopoietic and nonhematopoietic compartments. To assess the possible contribution of IGTP to the maintenance of parasite latency, partial chemotherapy was used to allow the establishment of chronic infection in IGTP-deficient animals. Upon cessation of drug treatment, these animals showed delayed mortality compared with similarly infected and treated IFN-gamma-deficient or inducible nitric oxide synthase-deficient mice, which succumbed rapidly. Parallel experiments performed with drug-treated bone marrow chimeras supported a role for the hematopoietic compartment in this NO-dependent, IGTP-independent control of chronic infection. Taken together, our findings demonstrate that host resistance mediated by IGTP is a Stat1-induced function which in the case of T. gondii acts predominantly to restrict acute as opposed to chronic infection. This effector mechanism requires expression of IGTP in cells of both hematopoietic and nonhematopoietic origin. In contrast, in latent infection, hematopoietically derived cells mediate resistance by means of a largely NO-dependent pathway.
引用
收藏
页码:6933 / 6939
页数:7
相关论文
共 39 条
  • [1] Boehm U, 1998, J IMMUNOL, V161, P6715
  • [2] Mechanism of inducible nitric oxide synthase inactivation by aminoguanidine and L-N6-(1-iminoethyl)lysine
    Bryk, R
    Wolff, DJ
    [J]. BIOCHEMISTRY, 1998, 37 (14) : 4844 - 4852
  • [3] CARLOW DA, 1995, J IMMUNOL, V154, P1724
  • [4] Cerávolo IP, 1999, INFECT IMMUN, V67, P2233
  • [5] Inactivation of LRG-47 and IRG-47 reveals a family of interferon γ-inducible genes with essential, pathogen-specific roles in resistance to infection
    Collazo, CM
    Yap, GS
    Sempowski, GD
    Lusby, KC
    Tessarollo, L
    Woude, GFV
    Sher, A
    Taylor, GA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (02) : 181 - 187
  • [6] A SENSITIVE IMMUNOCHEMICAL ASSAY FOR BIOLOGICALLY-ACTIVE MUIFN-GAMMA
    CURRY, RC
    KIENER, PA
    SPITALNY, GL
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 104 (1-2) : 137 - 142
  • [7] MULTIPLE DEFECTS OF IMMUNE CELL-FUNCTION IN MICE WITH DISRUPTED INTERFERON-GAMMA GENES
    DALTON, DK
    PITTSMEEK, S
    KESHAV, S
    FIGARI, IS
    BRADLEY, A
    STEWART, TA
    [J]. SCIENCE, 1993, 259 (5102) : 1739 - 1742
  • [8] Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection
    Denkers, EY
    Gazzinelli, RT
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (04) : 569 - +
  • [9] Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts
    Dubey, JP
    Lindsay, DS
    Speer, CA
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (02) : 267 - +
  • [10] PATHO-PHYSIOLOGY OF TOXOPLASMOSIS
    FRENKEL, JK
    [J]. PARASITOLOGY TODAY, 1988, 4 (10): : 273 - 278